Skip to main content

Advertisement

Log in

Endorsement of CONSORT by Chinese medical journals: A survey of “instruction to authors”

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To determine the extent to which Chinese medical (CM) journals incorporate Consolidated Standards for Reporting of Trials (CONSORT) into their “instruction to authors”.

Methods

We reviewed the latest “instruction to authors” of the CM journals in China which indexed by MEDLINE in 2010 or Excerpta Medica Database (EMBASE) in 2012 and extracted all information of CONSORT, International Committee of Medical Journal Editors (ICMJE), other reporting guidelines or clinical trial registration. By reading the instructions to authors and reviewing recent studies published in those journals, those that do not publish clinical trials were excluded. We also contacted each of journals by telephone on contributor’s status to ask them whether mentioned CONSORT in their instructions and incorporated it into their editorial and peer-review process. Full-text papers of randomized controlled trials (RCTs, from January 2011 to March 2012) published in the journals which mentioned “CONSORT” in their instructions for authors were downloaded.

Results

Seven CM journals were included. Three of these journals mentioned CONSORT in its instructions. By telephone survey, all journals gave responses and all respondents knew CONSORT statement. Three of 7 journals required authors to comply with the CONSORT statement and provide the CONSORT checklist and a flow chart of the trial. The rest 4 journals recommended authors of RCTs to refer to the CONSORT statement. From January 2011 to March 2012, a total of 50 RCTs were obtained from the 3 journals endorsing the CONSORT statement; 17 (17/50, 34%) contained a flow diagram in their manuscript, and none of those RCTs had mentioned the trial registration information.

Conclusions

The endorsement of CONSORT by CM journals’ “instruction to authors” was not satisfactory. The spread of CONSORT endorsement should be wider in instructing the performance of CM clinical trials in the future. Chinese journals should introduce CONSORT to their authors and require authors to comply with CONSORT when they submit their research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Xu L, Li J, Zhang MM, Ai CL, Wang L. Chinese authors do need CONSORT: Reporting quality assessment for five leading Chinese medical journals. Contemp Clin Trials 2008;29:727–731.

    Article  CAS  PubMed  Google Scholar 

  2. Folkes A, Urquhart R, Grunfeld E. Are leading medical journals following their own policies on CONSORT reporting? Contemp Clin Trials 2008;29:843–846.

    Article  PubMed  Google Scholar 

  3. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276:637–639.

    Article  CAS  PubMed  Google Scholar 

  4. Davidoff F. News from the International Committee of Medical Journal Editors. Ann Intern Med 2000;133:229–231.

    Article  CAS  PubMed  Google Scholar 

  5. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010;7:e1000251. doi:10.1371/journal.pmed.1000251

    Article  PubMed Central  PubMed  Google Scholar 

  6. Wu TX, Li YP, Bian ZX, Li TQ, Li J, Dagenais S, et al. Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM). Chin J Evid-based Med (Chin) 2007;7:625–630.

    Google Scholar 

  7. Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J 2006;185:263–267.

    Google Scholar 

  8. Altman DG. Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ 2005;330:1056–1057.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal’ Instructions to Authors’. Trials 2008;9:20.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Li XQ, Tao KM, Zhou QH, Moher D, Chen HY, Wang FZ, et al. Endorsement of the CONSORT statement by high-impact medical journals in China: a survey of Iinstructions for authors and published papers. PLoS ONE 2012;7:e30683. doi:10.1371/journal.pone.0030683

    Article  PubMed Central  PubMed  Google Scholar 

  11. Egger M, Jüni P, Bartlett C. Value of flow diagrams in reports of randomized controlled trials. JAMA 2001;285:1996–1999.

    Article  CAS  PubMed  Google Scholar 

  12. Wright JR, Bouma S, Dayes I, Sussman J, Simunovic MR, Levine MN, et al. The importance of reporting patient recruitment details in phase III trials. J Clin Oncol 2006;24:843–845.

    Article  PubMed  Google Scholar 

  13. Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007;297:1233–1240.

    Article  PubMed  Google Scholar 

  14. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.

    Article  PubMed Central  PubMed  Google Scholar 

  15. De Angelisa C, Drazenb JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 2004;364:911–912.

    Article  Google Scholar 

  16. Why is trial registration important? 2012, http://www.who.int/ictrp/trial_reg/en/index.htmlint/ictrp/trial_reg/en/index.html

  17. Zhang C, Zha QL, He YT, Jiang M, Lv C, Lv AP. The extraarticular symptoms influence ACR response in the treatment of rheumatoid arthritis with biomedicine: a singleblind, randomized, controlled, multicenter trial in 194 patients. J Tradit Chin Med 2011;31:50–55.

    Article  PubMed  Google Scholar 

  18. Shi ZF, Zhou QQ, Xiang L, Ma SD, Yan CJ, Luo H. Three preparations of compound Chinese herbal medicines for de-adaptation to high altitude: a randomized, placebocontrolled trial. J Chin Integr Med (Chin) 2011;9:395–401.

    Article  Google Scholar 

  19. Wang TF, Xue XL, Zhang YJ, Han P, Li Z, Wang WP, et al. Effects of Xiaopi Yishen herbal extract granules in treatment of fatigue-predominant subhealth due to Liverqi stagnation and Spleen-qi deficiency: a prospective, randomized, placebo-controlled and double-blind clinical trial. J Chin Integr Med (Chin) 2011;9:515–524.

    Article  Google Scholar 

  20. Susuana Kuek, Wang WJ, Gui SQ. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial. J Chin Integr Med (Chin) 2011;9:395–401.

    Article  Google Scholar 

  21. Yan GY, Xu ZY, Deng HB, Wan ZY, Zhang L, Zhu JY. Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao Decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial. J Chin Integr Med (Chin) 2011;9:525–530.

    Article  Google Scholar 

  22. Zheng ZX, Wang J, Hou JS, Ma L, Jiang CB. A traditional Chinese medicine therapy warming meridians to nourish blood in treating chronic pain due to soft tissue injury of the neck and shoulder: a randomized controlled trial. J Chin Integr Med (Chin) 2011;9:153–157.

    Article  Google Scholar 

  23. Zheng ZX, Wang J, Hou JS, Ma L, Jiang CB. A traditional Chinese medicine therapy warming meridians to nourish blood in treating chronic pain due to soft tissue injury of the neck and shoulder: a randomized controlled trial. J Chin Integr Med (Chin) 2011;9:153–157.

    Article  Google Scholar 

  24. Wei XL, Feng R, Zhao ZQ, Jing ZP. Efficacy of Chinese herbal medicine Mailuo Shutong Granule and Hirudoid cream for chronic venous disorder-induced pigmentation in lower extremities: a prospective, randomized controlled trial. J Chin Integr Med (Chin) 2011;9:866–870.

    Article  Google Scholar 

  25. Shu S, Li TM, Fang FF, He HL, Zhou QH, Gu W, et al. Relieving pre-exam anxiety syndrome with wrist-ankle acupuncture: a randomized controlled trial. J Chin Integr Med (Chin) 2011;9:605–610.

    Article  Google Scholar 

  26. Chen I, Bi XY, Zhu LX, Qiu YQ, Ding S, Deng BQ. Flavonoids of puerarin versus tanshinone j1 A for ischemic stroke: a randomized controlled trial. J Chin Inter Med (Chin) 2011;9:1215–1220.

    Article  Google Scholar 

  27. Guo LK. Zhang CX, Guo XF. Acupuncture combined with Chinese herbal medicine plantain and Senna Granule in treatment of functional constipation: a randomized, controlled trial. J Chin Integr Med (Chin) 2011;9:1206–1214.

    Article  Google Scholar 

  28. Li M, Yang MH, Liu Y. Effects of Chinese herbal medicine Bushen Huoxue Granule on quality of life of patients with Parkinson disease: a randomized, double blinded and placebo controlled trial. J Chin Integr Med (Chin) 2012;10:310–317.

    Article  Google Scholar 

  29. Zhu YF, Luo HM, Deng ZL, Fu DY, Yao W, Dai J. Effects of the Chinese patent medicine, Honghua Injection, on platelet glycoprotein IIb/IIIa receptors in patients with acute coronary syndrome: a randomized controlled trial. J Chin Integr Med (Chin) 2012;10:318–323.

    Article  Google Scholar 

  30. Li BS, Li ZH, Tang XD, Zhang LY, Zhao YP, Bian LQ, et al. A randomized, controlled, double-blinded and doubledummy trial of the effect of Tongjiang Granule (通降颗粒) on the nonerosive reflux disease of and Gan (肝)-Wei (胃) incoordination syndrome. Chin J Integr Med 2011;17:339–345.

    Article  PubMed  Google Scholar 

  31. Cao B, Li ST, Li Z, Deng WL. Yiqi Zhuyu Decoction (益 气逐瘀汤) combined with FOLFOX-4 as first-line therapy in metastatic colorectal cancer. Chin J Integr Med 2011;17:593–599.

    Article  PubMed  Google Scholar 

  32. Lu CJ, Xiang Y, Xie XL, Yi ML, He ZH. A randomized controlled single-blind clinical trial on 84 outpatients with psoriasis vulgaris by auricular therapy combined with optimized Yinxieling Formula (银屑灵优化方). Chin J Integr Med 2012;8:186–191.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hong-cai Shang  (商洪才).

Additional information

These two authors contributed equally to this work

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiao, L., Hu, J., Zhang, L. et al. Endorsement of CONSORT by Chinese medical journals: A survey of “instruction to authors”. Chin. J. Integr. Med. 20, 510–515 (2014). https://doi.org/10.1007/s11655-014-1865-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-014-1865-8

Keywords

Navigation